Introducing DPx Holdings B.V.
DPx Holdings B.V. is the “umbrella name” for our three business units specializing in pharmaceutical services, fine chemicals and proprietary products and technologies. Formed as part of a USD $2.6 billion transaction between JLL Partners and Royal DSM in March 2014, we are positioned to add scale, new value chain capabilities and technologies, as well as expand our end-to-end service offerings as a comprehensive solution provider to the pharmaceutical industry.
Emerged from the shared vision between Patheon and DSM Pharmaceutical Products (DPP) – the DPx vision is built upon the collective reputations of quality, innovation, customer service and operational excellence. These same core commitments are at the center of each of our business units, which operate under the Patheon, DSM Fine Chemicals and Banner Life Sciences brand names.